Stifel Financial Corp Buys Shares of 10,075 Abrdn Healthcare Investors (NYSE:HQH)

Stifel Financial Corp purchased a new position in shares of Abrdn Healthcare Investors (NYSE:HQH) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 10,075 shares of the financial services provider’s stock, valued at approximately $188,000.

Several other hedge funds also recently modified their holdings of HQH. Truvestments Capital LLC bought a new position in Abrdn Healthcare Investors during the third quarter worth $46,000. Northwest Investment Counselors LLC bought a new position in shares of Abrdn Healthcare Investors during the 3rd quarter worth about $57,000. EverSource Wealth Advisors LLC acquired a new position in shares of Abrdn Healthcare Investors during the second quarter valued at about $93,000. Rothschild Investment LLC acquired a new position in shares of Abrdn Healthcare Investors during the second quarter valued at about $101,000. Finally, Teamwork Financial Advisors LLC bought a new stake in shares of Abrdn Healthcare Investors in the third quarter valued at about $201,000. 32.60% of the stock is owned by institutional investors.

Abrdn Healthcare Investors Stock Performance

Shares of HQH opened at $16.19 on Tuesday. The stock’s 50-day moving average price is $17.52 and its 200 day moving average price is $18.11. Abrdn Healthcare Investors has a 12-month low of $15.76 and a 12-month high of $19.79.

Abrdn Healthcare Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Thursday, November 21st will be given a dividend of $0.62 per share. The ex-dividend date of this dividend is Thursday, November 21st. This is a boost from Abrdn Healthcare Investors’s previous quarterly dividend of $0.59. This represents a $2.48 dividend on an annualized basis and a dividend yield of 15.32%.

Abrdn Healthcare Investors Profile

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.